We are live on ! Find out more
PROK icon

ProKidney

55 hedge funds and large institutions have $44.1M invested in ProKidney in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less funds holding

Funds holding: 6155 (-6)

20.42% less ownership

Funds ownership: 60.44%40.01% (-20%)

39% less capital invested

Capital invested by funds: $72.2M → $44.1M (-$28.1M)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

50% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 24

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $10K

Holders
55
Holders Change
-6
Holders Change %
-9.84%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
7
Increased
12
Reduced
24
Closed
13
Calls
Puts
$10K
Net Calls
-$10K
Net Calls Change
-$4K

PROK Hedge Fund Activity: Q1 2024 in Review

55 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q1 2024, worth a combined $44.1M — down 39% from $72.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PROK and 7 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 12 added.

The largest buyer was Fidelity Investments, adding an estimated $355K. The largest seller was Morgan Stanley, cutting an estimated $17.7M.

  • 55 institutional investors held ProKidney (PROK) as of Q1 2024, down from 61 in Q4 2023.
  • Funds reported $44.1M of ProKidney stock for Q1 2024, down 39% quarter-over-quarter.
  • 7 funds opened new ProKidney positions in Q1 2024 and 13 closed out, a net change of -6 holders.
  • The largest ProKidney buyer in Q1 2024 was Fidelity Investments, an estimated $355K added.
  • The largest ProKidney seller in Q1 2024 was Morgan Stanley, an estimated $17.7M sold.

Based on aggregated 13F filings for Q1 2024.